Cormorant Asset Management, LP

13F Portfolio Filings

Latest 13F report
Q2 2024 - Aug 14, 2024
Value $
$1.72B
Signature - Title
Neb Obradovic - CCO
Location
200 Clarendon Street, 52 Nd Floor, Boston, MA
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q2 2024 47 $1.72B +$351M -$591M -$240M MLTX, CRBP, ACLX, PCVX, LBPH 13F-HR 8/14/2024, 03:05 PM
Q1 2024 56 $2.27B +$569M -$504M +$65.1M MLTX, EYPT, ACLX, ALPN, BBIO 13F-HR 5/15/2024, 03:22 PM
Q4 2023 47 $2.09B +$534M -$613M -$79.5M MLTX, AMAM, EYPT, BBIO, ACLX 13F-HR 2/14/2024, 03:11 PM
Q3 2023 49 $1.71B +$290M -$253M +$36.4M MLTX, BBIO, AMAM, ACLX, APLS 13F-HR 11/14/2023, 03:25 PM
Q2 2023 61 $1.76B +$300M -$426M -$126M MLTX, AMAM, APLS, BMEA, BBIO 13F-HR 8/14/2023, 03:19 PM
Q1 2023 72 $1.52B +$319M -$334M -$15.4M RXDX, MLTX, BMEA, APLS, AMAM 13F-HR 5/15/2023, 03:34 PM
Q4 2022 72 $1.49B +$181M -$213M -$32.2M RXDX, APLS, ACLX, MLTX, RNA 13F-HR 2/14/2023, 03:17 PM
Q3 2022 72 $1.42B +$268M -$365M -$97.6M RXDX, APLS, DSGN, ERAS, ACLX 13F-HR 11/14/2022, 03:23 PM
Q2 2022 79 $1.29B +$253M -$183M +$69.7M TPTX, DSGN, ERAS, RXDX, APLS 13F-HR 8/15/2022, 03:08 PM
Q1 2022 77 $1.3B +$230M -$126M +$104M TPTX, ERAS, DSGN, RXDX, GRNA 13F-HR 5/16/2022, 03:07 PM
Q4 2021 78 $1.68B +$152M -$344M -$192M ERAS, TPTX, DSGN, RXDX, FMTX 13F-HR 2/14/2022, 03:19 PM
Q3 2021 88 $2.46B +$465M -$348M +$117M ERAS, TPTX, AVIR, FMTX, RVMD 13F-HR 11/15/2021, 03:14 PM
Q2 2021 100 $2.56B +$487M -$887M -$400M TPTX, AVIR, FMTX, BBIO, DSGN 13F-HR 8/16/2021, 03:13 PM
Q1 2021 115 $3.47B +$728M -$419M +$309M AVIR, TPTX, DSGN, BBIO, FMTX 13F-HR 5/17/2021, 03:46 PM
Q4 2020 99 $3.44B +$1.01B -$450M +$562M TPTX, AVIR, BBIO, FMTX, OLMA 13F-HR 2/16/2021, 03:21 PM
Q3 2020 87 $2.27B +$329M -$449M -$120M TPTX, FMTX, RVMD, BBIO, CCXI 13F-HR 11/16/2020, 04:13 PM
Q2 2020 77 $2.28B +$364M -$413M -$48.7M TPTX, FMTX, CCXI, PRNB, BBIO 13F-HR 8/14/2020, 03:17 PM
Q1 2020 68 $1.76B +$316M -$285M +$30.8M TPTX, PRNB, BBIO, CCXI, XLRN 13F-HR 5/15/2020, 03:07 PM
Q4 2019 61 $2.27B +$453M -$307M +$146M TPTX, RETA, MRTX, CCXI, PRNB 13F-HR 2/14/2020, 03:36 PM
Q3 2019 68 $1.38B +$168M -$125M +$42.4M TPTX, MRTX, APLS, RETA, BBIO 13F-HR 11/14/2019, 03:10 PM
Q2 2019 67 $1.58B +$459M -$244M +$215M TPTX, MRTX, RETA, APLS, BBIO 13F-HR 8/14/2019, 03:17 PM
Q1 2019 63 $1.4B +$414M -$402M +$11.7M IFRX, MRTX, ASND, APLS, ANAB 13F-HR 5/15/2019, 03:31 PM
Q4 2018 65 $1.1B +$159M -$163M -$3.57M MRTX, ANAB, TSRO, APLS, IFRX 13F-HR 2/14/2019, 03:35 PM
Q3 2018 60 $1.39B +$170M -$190M -$19.5M ANAB, MRTX, NKTR, AVRO, APLS 13F-HR 11/14/2018, 03:15 PM
Q2 2018 56 $1.24B +$275M -$108M +$168M APLS, MRTX, ANAB, NKTR, IFRX 13F-HR 8/14/2018, 03:11 PM
Q1 2018 49 $1.15B +$250M -$121M +$129M NKTR, ANAB, APLS, MRTX, IFRX 13F-HR 5/15/2018, 03:54 PM
Q4 2017 49 $863M +$421M -$203M +$218M ANAB, NKTR, APLS, BPMC, MYOK 13F-HR 2/14/2018, 03:39 PM
Q3 2017 51 $566M +$111M -$217M -$107M MYOK, RXDX, OMER, ANAB, TBPH 13F-HR 11/14/2017, 03:17 PM
Q2 2017 71 $602M +$112M -$156M -$44.1M PTLA, TBPH, BLUE, QTNT, OMER 13F-HR 8/14/2017, 03:15 PM
Q1 2017 75 $689M +$62.4M -$154M -$91.7M TBPH, NVRO, PTI, GLPG, ANAB 13F-HR 5/15/2017, 03:23 PM
Q4 2016 77 $742M +$99.8M -$136M -$36.1M PTI, TBPH, NVRO, ALDR, EGRX 13F-HR 2/14/2017, 03:22 PM
Q3 2016 84 $907M +$179M -$150M +$29.1M ALDR, NVRO, TBPH, NERV, PTI 13F-HR 11/14/2016, 02:58 PM
Q2 2016 84 $705M +$138M -$123M +$14.7M ALDR, NVRO, HRTX, TSRO, NKTR 13F-HR 8/15/2016, 04:12 PM
Q1 2016 84 $664M +$142M -$56M +$85.6M ALDR, HRTX, SAGE, OMER, NKTR Restatement 5/17/2016, 04:50 PM
Q4 2015 82 $836M +$139M -$44.1M +$94.6M ALKS, DYAX, HRTX, EGRX, NBIX 13F-HR 2/16/2016, 04:11 PM
Q3 2015 87 $626M +$87.6M -$53.4M +$34.2M HRTX, ALKS, NBIX, DYAX, ARDX 13F-HR 11/16/2015, 04:08 PM
Q2 2015 80 $752M +$157M -$169M -$12.8M ALKS, HRTX, RCPT, ALDR, DYAX 13F-HR 8/14/2015, 04:22 PM
Q1 2015 71 $647M +$102M -$194M -$91.2M RCPT, ALKS, PBYI, EGRX, BMY 13F-HR 5/15/2015, 04:18 PM
Q4 2014 70 $649M +$180M -$134M +$46.7M RCPT, PBYI, CELG, OVAS, ALKS 13F-HR 2/17/2015, 04:20 PM
Q3 2014 65 $486M +$178M -$73.5M +$104M PBYI, RCPT, JAZZ, DYAX, KERX 13F-HR 11/14/2014, 11:21 AM
Q2 2014 54 $377M +$139M -$181M -$41.8M RCPT, OMER, QCOR, KPTI, DYAX 13F-HR 8/14/2014, 11:21 AM
Q1 2014 46 $435M +$202M -$126M +$75.8M MDVN, CBST, PBYI, BMRN, RCPT 13F-HR 5/15/2014, 11:20 AM
Q4 2013 37 $345M $0 $0 MDVN, CBST, KERX, DYAX, PBYI 13F-HR 2/14/2014, 10:50 AM